ANDA 202328, held by Eugia Pharma. Levofloxacin.
As of Nov 16, 2026, ANDA 202328 (Levofloxacin), held by Eugia Pharma, was first approved by FDA on Jan 24, 2013, with 8 approved supplements and 0 published complete response letters.
Levofloxacin injection is indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. Levofloxacin injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e.g., patient cannot tolerate an oral dosage form). Levofloxacin injection is a fluoroquinolone antibacterial indicated in adults (≥18 years of age) with infections caused by designated, susceptible bacteria (1, 12.4). Pneumonia: Nosocomial and Community Acquired (1.2, 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 24, 2013 | Original application | Approved | None posted |
| LevofloxacinEQ 500MG/20ML (EQ 25MG/ML) · injectable;injection | Levofloxacin | Discontinued |
| LevofloxacinEQ 750MG/30ML (EQ 25MG/ML) · injectable;injection | Levofloxacin | Discontinued |
| Sep 20, 2024 | Supplement 14Labeling · Standard review | Approved | None posted |
| May 3, 2019 | Supplement 10Labeling · Standard review | Approved | None posted |
| Oct 18, 2018 | Supplement 9Labeling · Standard review | Approved | None posted |
| Oct 15, 2018 | Supplement 7Labeling · Standard review | Approved | None posted |
| Oct 15, 2018 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jul 15, 2016 | Supplement 6Labeling · Standard review | Approved | None posted |
| Feb 28, 2014 | Supplement 5Labeling · Standard review | Approved | None posted |
| Nov 5, 2013 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jan 24, 2013 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters